Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3332580 | HIV & AIDS Review | 2008 | 4 Pages |
Abstract
Disorders in lipid metabolism exist in most patients treated for the long time. In our study were included 186 patients on antiretroviral treatment lasting 96 weeks treated either with AZT/3TC or with D4T/3TC. Performed studies have shown that both d4T/3TC and AZT/3TC regimens are effective as backbone of CART. Similar immunological values are achieved using above mentioned regimens. Elevation of TG and TC level during antiretroviral therapy is much more frequent in persons treated with d4T/3TC and is not dependent on type of the third drug used.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
PaweÅ ÅwiÄcki, Ewa FirlÄ
g-Burkacka, Elżbieta BÄ
kowska, Anna Ignatowska, Piotr Pulik, Andrzej Horban,